Unigestion Holding SA Has $869,000 Stock Position in HCP, Inc. (NYSE:HCP)

Share on StockTwits

Unigestion Holding SA decreased its stake in shares of HCP, Inc. (NYSE:HCP) by 98.8% during the 3rd quarter, Holdings Channel reports. The firm owned 24,400 shares of the real estate investment trust’s stock after selling 1,991,900 shares during the period. Unigestion Holding SA’s holdings in HCP were worth $869,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Quest Capital Management Inc. ADV acquired a new position in shares of HCP during the 3rd quarter worth approximately $28,000. Westside Investment Management Inc. acquired a new position in shares of HCP during the 2nd quarter worth approximately $31,000. Bartlett & Co. LLC acquired a new position in shares of HCP during the 3rd quarter worth approximately $36,000. NEXT Financial Group Inc increased its position in shares of HCP by 181.3% during the 2nd quarter. NEXT Financial Group Inc now owns 1,125 shares of the real estate investment trust’s stock worth $36,000 after purchasing an additional 725 shares during the last quarter. Finally, CSat Investment Advisory L.P. increased its position in shares of HCP by 77.6% during the 2nd quarter. CSat Investment Advisory L.P. now owns 1,165 shares of the real estate investment trust’s stock worth $37,000 after purchasing an additional 509 shares during the last quarter. 95.80% of the stock is currently owned by hedge funds and other institutional investors.

Several research analysts have weighed in on HCP shares. TheStreet raised HCP from a “c+” rating to a “b-” rating in a research report on Friday, August 2nd. Argus raised HCP from a “hold” rating to a “buy” rating in a research report on Tuesday, September 10th. KeyCorp boosted their price target on HCP from $34.00 to $37.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Morgan Stanley lifted their target price on HCP from $32.00 to $35.00 and gave the stock an “equal weight” rating in a research note on Tuesday, September 17th. Finally, ValuEngine downgraded HCP from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $36.78.

In related news, COO Thomas Klaritch sold 35,014 shares of the business’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $36.02, for a total value of $1,261,204.28. Following the completion of the sale, the chief operating officer now directly owns 230,529 shares in the company, valued at approximately $8,303,654.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.13% of the company’s stock.

Shares of NYSE HCP traded down $0.89 during midday trading on Friday, hitting $33.64. 4,003,528 shares of the company’s stock were exchanged, compared to its average volume of 2,801,829. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.01. HCP, Inc. has a 12 month low of $26.58 and a 12 month high of $37.93. The company’s 50 day moving average price is $36.24 and its 200 day moving average price is $33.42. The firm has a market capitalization of $17.57 billion, a PE ratio of 18.48, a price-to-earnings-growth ratio of 6.81 and a beta of 0.22.

HCP (NYSE:HCP) last issued its earnings results on Wednesday, October 30th. The real estate investment trust reported ($0.09) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by ($0.52). HCP had a return on equity of 12.78% and a net margin of 43.66%. The business had revenue of $538.00 million for the quarter, compared to the consensus estimate of $503.65 million. During the same quarter in the prior year, the firm posted $0.44 earnings per share. The business’s revenue was up 18.0% compared to the same quarter last year. On average, equities research analysts anticipate that HCP, Inc. will post 1.75 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, November 19th. Investors of record on Monday, November 4th will be paid a $0.37 dividend. The ex-dividend date is Friday, November 1st. This represents a $1.48 annualized dividend and a yield of 4.40%. HCP’s dividend payout ratio (DPR) is presently 81.32%.

HCP Company Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Read More: What is meant by holder of record?

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.